Commentary with lead author Kelly Stevens: Our nationwide network of BME women faculty collectively argue that racial funding disparity by the National Institutes of Health (NIH) remains the most insidious barrier to success of Black faculty in our profession. We thus refocus attention on this critical barrier and suggest solutions on how it can be dismantled.
A new approach uses lasers and molecular tethers to pattern 3D cell fate in natural scaffolds for tissue engineering.
Bioprinted tissues with entangled vascular networks for air and blood are a major step toward 3D printing of replacement organs. Bioengineers from University of Washington and Rice University teamed to create the 3D bioprinted vascular networks and tested them in mice.
Engineered human liver tissue “seeds” blossom after transplant, offer an alternative strategy to organ transplantation
Researchers discovered that a "seed" of human liver and supporting cells "blossomed" to 50 times its original size in mice. The work could lead to clinical solutions for organ disease and failure, and serve as an alternative to whole organ transplant.
The event marked the third year the UW Institute for Stem Cell and Regenerative Medicine visited Mill Creek Middle School to lead activities designed to teach students about science and health.
Dr. Kelly Stevens, an assistant professor in UW Bioengineering and in Pathology, has received a 2016 National institutes of Health (NIH) Director’s New Innovator Award in support of her work to build artificial human tissues from stem cells, and to remotely control these tissues after implantation in a patient.
This award recognizes Dr. Stevens' efforts to address the clinical challenge of liver disease by building an artificial engineered liver using pluriopotent stem cells.
UW Bioengineering and Pathology announce new assistant professors Jennifer Davis and Kelly Stevens. They will be part of the UW heart regeneration program.